Krahn, Natalie
Natalie Krahn
Assistant Professor, Biochemistry & Molecular Biology Department
Engineering tRNA technology to build novel proteins with selenocysteine.
Hummels, Kate
Kate Hummels
Assistant Professor, Microbiology Department
Our work focuses on understanding the regulation of cell envelope biosynthesis in bacteria using genetic, biochemical, and cell biological approaches.
Majewska, Ania
Ania Majewska
Assistant Professor, Physiology & Pharmacology Department
Course-based undergraduate research experiences, virtual reality in learning physiology and anatomy, culturally responsive teaching.
Hoarfrost, Adrienne
Adrienne Hoarfrost
Assistant Professor, Marine Sciences Department
Marine microbiology; carbon cycling and biogeochemistry; AI/machine learning for biology; bioinformatics; astrobiology; space biology; marine biotech.
VanDrisse, Chelsey
Chelsey VanDrisse
Assistant Professor, Genetics Department
Our lab seeks to uncover novel regulatory mechanisms of biofilm formation to undermine bacterial survival in chronic infections.
Billmyre, Blake
Blake Billmyre
Assistant Professor, Pharmaceutical & Biomedical Sciences Department/Infectious Diseases Department
High throughput genetics to better understand evolution of fungal pathogens and drive antifungal drug discovery.
Billmyre, Katie
Katie Billmyre
Assistant Professor, Genetics Department
Meiotic chromosome biology using Drosophila as a model system.
Kanthasamy, Arthi
Arthi Kanthasamy
Professor, Physiology & Pharmacology Department
Research focuses on cellular and molecular mechanisms of neurodegeneration, identifying novel immunomodulatory drugs, discovering biomarkers for diabetes, Parkinson’s and Alzheimer’s diseases related dementia.
Kanthasamy, Anumantha G.
Anumantha G. Kanthasamy
John H. “Johnny” Isakson Chair and Georgia Research Alliance Eminent Scholar
Professor, Physiology & Pharmacology Department
Director, Center for Neurological Disease Research
Research focuses on cellular and molecular mechanisms of neurodegeneration, identifying novel druggable targets, discovering prodromal biomarkers and novel reengineered gut microbiome based therapeutics for treatment of neurological disorders such as Parkinson’s and Alzheimer’s diseases and related dementia.